Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 4, 2025 • 6:31 PM ET

Date/Time Source News Release
10/03/2023 04:30 PM EDT ACCESSWIRE BioNxt Solutions Announces Change of Directors
09/28/2023 07:30 PM EDT ACCESSWIRE Bionxt Solutions Announces Closing of Second Tranche of Non-Brokered Private Placement
08/04/2023 08:12 PM EDT ACCESSWIRE BioNxt Solutions Announces Non-Brokered Private Placement
08/02/2023 03:00 AM EDT ACCESSWIRE BioNxt Signs LOI for Acquisition of IP and Co-Development of ODF Drug Reformulation for Neurodegenerative Disease
05/15/2023 03:05 AM EDT ACCESSWIRE BioNxt Receives Approval for European Clinical Study of Transdermal Rotigotine Patch for Parkinson's Disease
05/09/2023 03:05 AM EDT ACCESSWIRE BioNxt Successfully Completes Pilot Study for Contract Development Customer
04/24/2023 03:05 AM EDT ACCESSWIRE BioNxt Secures Contract to Develop and Manufacture ODF Product for International Pharmaceutical Company
04/17/2023 03:05 AM EDT ACCESSWIRE BioNxt Acquires Commercial Coating and Cutting Equipment to Build Out European Commercial Manufacturing Capacity
04/14/2023 09:11 PM EDT ACCESSWIRE BioNxt Reports on Enteric Coating Drug Delivery Program
04/03/2023 10:50 PM EDT ACCESSWIRE BioNxt Solutions Announces Closing of Non-Brokered Private Placement and Grant of Stock Options
Page

Additional News

As of June 4, 2025 • 6:31 PM ET

Date/Time Source News Release
12/12/2022 08:30 AM EST InvestorBrandNetwork InvestorNewsBreaks - BioNxt Solutions Inc. (CSE: BNXT) (OTCQB: XPHYF) (FSE: 4XT) to Expand Portfolio with Precision Drug Delivery Technology
12/12/2022 05:30 AM EST SeekingAlpha BioNxt Solutions signs term sheet for drug coating platform
11/21/2022 08:30 AM EST InvestorBrandNetwork InvestorNewsBreaks - BioNxt Solutions Inc. (CSE: BNXT) (OTCQB: XPHYF) (FSE: 4XT) Holds Key Meetings, Advances Product at Frankfurt CPHI Conference
11/10/2022 03:20 PM EST SeekingAlpha XPhyto Therapeutics to be renamed BioNxt Solutions
11/10/2022 08:30 AM EST InvestorBrandNetwork InvestorNewsBreaks - XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Changes Name to BioNxt Solutions Inc.
10/18/2022 08:30 AM EDT InvestorBrandNetwork InvestorNewsBreaks - XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Announces Major Milestone on Path to Commercialization of Lead Product
10/11/2022 08:30 AM EDT InvestorBrandNetwork InvestorNewsBreaks - XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Announces Completion of Rotigotine TDS Patch Study
10/05/2022 08:30 AM EDT InvestorBrandNetwork InvestorNewsBreaks - XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE:4XT) Inks LOI to Identify Manufacturing, Strategic Business Opportunities
10/05/2022 03:46 AM EDT SeekingAlpha XPhyto inks LOI for US manufacturing and strategic business opportunities
09/20/2022 08:30 AM EDT InvestorBrandNetwork InvestorNewsBreaks - XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Announces Patent Application for Novel Psychedelic Compound Library
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.